176520-13-1

Basic information

• Product Name: Scutebarbatine A
• Synonyms: Scutebarbatine A
• CAS NO: 176520-13-1
• Molecular Formula: C32H34N2O7
• Molecular Weight: 558.62156
• EINECS: 200-258-5
• Mol File: 176520-13-1.mol

Chemical Properties

• Boiling Point: 742.1±60.0 °C(Predicted)
• Appearance: /
• Density: 1.31±0.1 g/cm3(Predicted)
• PKA: 13.04±0.70(Predicted)
• CAS DataBase Reference: Scutebarbatine A(CAS DataBase Reference)
• NIST Chemistry Reference: Scutebarbatine A(176520-13-1)
• EPA Substance Registry System: Scutebarbatine A(176520-13-1)

Safety Data

• Hazardous Substances Data: 176520-13-1(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
Scutebarbatine A is used as a potential therapeutic agent for various diseases due to its anti-tumor, anti-inflammatory, and anti-angiogenic properties. It is being investigated for its efficacy in treating cancer, cardiovascular diseases, and neurodegenerative disorders.
Used in Cancer Treatment:
Scutebarbatine A is used as an anti-tumor agent for its potential to inhibit tumor growth and progression. It may be employed in combination with conventional chemotherapeutic drugs to enhance chemo-sensitivity and improve therapeutic outcomes in resistant cases.
Used in Cardiovascular Disease Management:
Scutebarbatine A is used as a cardioprotective agent due to its antioxidant and anti-inflammatory properties. It may help in managing cardiovascular diseases by reducing inflammation and oxidative stress, which are key contributors to the development and progression of these conditions.
Used in Neurodegenerative Disorder Treatment:
Scutebarbatine A is used as a potential neuroprotective agent for its potential to mitigate the effects of neurodegenerative disorders. Its antioxidant and anti-inflammatory properties may help in slowing down the progression of these diseases by reducing oxidative stress and inflammation in the brain.
Note: The specific application types and reasons mentioned above are inferred from the general properties of Scutebarbatine A and its potential pharmacological activities. Further research is required to validate these uses and develop appropriate drug delivery systems for its therapeutic applications.